What is the clinical reputation of the Evra patch versus oral combination pills regarding venous thromboembolism risk in women over thirty-five who are non-smokers?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the clinical reputation of the Evra patch versus oral combination pills regarding venous thromboembolism risk in women over thirty-five who are non-smokers?
3 real searches · 1 real-search pass
Evra contraceptive patch venous thromboembolism risk compared combined oral contraceptives FDA label epidemiologyGoogle ↗
OBSERVED
CDC U.S. Medical Eligibility Criteria 2024 combined hormonal contraception age 35 nonsmoker venous thromboembolismGoogle ↗
OBSERVED
FSRH combined hormonal contraception transdermal patch VTE risk compared oral contraception guidelineGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
Evra contraceptive patch venous thromboembolism risk compared combined oral contraceptives FDA label epidemiology Google ↗
CDC U.S. Medical Eligibility Criteria 2024 combined hormonal contraception age 35 nonsmoker venous thromboembolism Google ↗
FSRH combined hormonal contraception transdermal patch VTE risk compared oral contraception guideline Google ↗
- Nonoral combined hormonal contraceptives and thromboembolism: a systematic review · pubmed.ncbi.nlm.nih.gov
- FSRH Guideline · fsrh.org
- Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. · pubmed.ncbi.nlm.nih.gov
- label · accessdata.fda.gov
- Ortho Evra (norelgestromin and ethinyl estradiol) · accessdata.fda.gov
- Evra, INN-norelgestromin/ethinyl estradiol · ema.europa.eu
- Combined hormonal contraception and the risk of venous thromboembolism: a guideline (2016) | American Society for Reproductive Medicine · asrm.org
- Appendix A: Summary of Classifications for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | Contraception · cdc.gov
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | Contraception · cdc.gov
- Appendices for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 · cdc.gov
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 · cdc.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
Evra contraceptive patch venous thromboembolism risk compared combined oral contraceptives FDA label epidemiology OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
CDC U.S. Medical Eligibility Criteria 2024 combined hormonal contraception age 35 nonsmoker venous thromboembolism OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FSRH combined hormonal contraception transdermal patch VTE risk compared oral contraception guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |